Pfizer Inc. (PFE)

Buy 9 S&P500 IDEAL "Safer" October Dividend Dogs

These 4 Dividend Stocks Offer Tempting Yields. But the Warning Signs Are Getting Harder to Ignore

Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

How Much More Dividend Income a Roth IRA Keeps on a Half-Million-Dollar Portfolio

CDs vs. Dividend Stocks: The Income Gap Could Be Bigger Than Retirees Think

$12,300 a Month in Dividends and Not One Bond: Is This Portfolio Too Good to Be True?

Pfizer's Dividend Yield Is Above 6%. Wall Street May Be Sending a Warning

Cancer Stocks to Consider as Oncology Innovation Accelerates

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

4 Household Name Stocks With Dividends in Danger

Pfizer: Previously Bearish, I'm Converting To A Cautious Bull (Rating Upgrade)

Pfizer Inc. $PFE Shares Sold by Sapient Capital LLC

Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.